Table 5.
Recipient species | Route of administration | Number of hepatocytes transplanted | Conclusions | Reference |
---|---|---|---|---|
Rat (ALF) | Intraperitoneal | 4×107 | Hepatocytes prolonged survival | Makowka 1980a (118) |
Rat (ALF) | Intraperitoneal | 4×107 | Presensitization did not affect survival | Makowka 1980b (119) |
Rat (ALF) | Spleen | 1×108 | Hepatocyte graft survival was improved by daclizumab | Papagoras 2007 (133) |
Rat (ALF) | Spleen | 1×108 | Rapamycin offered no survival advantage | Lytras 2010 (134) |